[

covaxin

]
PAGE 12

Covid-19 vaccine update: UK to begin Pfizer vaccinations, Bharat Biotech seeks nod for emergency use in India

South Korea’s government has said it has signed deals with four firms-AstraZeneca, Pfizer, Moderna and Johnson & Johnson-to vaccinate a total of 44 million people.
FILE PHOTO: A logo of Pfizer is seen at the entrance to the Pfizer factory in Puurs, Belgium Dec. 3, 2020. REUTERS/Yves Herman/File Photo/File Photo(REUTERS)
FILE PHOTO: A logo of Pfizer is seen at the entrance to the Pfizer factory in Puurs, Belgium Dec. 3, 2020. REUTERS/Yves Herman/File Photo/File Photo(REUTERS)
Updated on Dec 08, 2020 08:07 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Haryana minister tests positive for Covid-19

Vij’s illness and participation in the trial for Bharat Biotech’s Covaxin triggered confusion over the vaccine, prompting the company to clarify that the shot is meant to be protective only two weeks after the second dose – which itself is given after a gap of 28 days following the first dose.
Earlier, he announced in a tweet: “I have been tested Corona positive. I am admitted in Civil Hospital Ambala Cantt. All those who have come in close contact to me are advised to get themselves tested for corona,” he tweeted.(Sant Arora/HT)
Earlier, he announced in a tweet: “I have been tested Corona positive. I am admitted in Civil Hospital Ambala Cantt. All those who have come in close contact to me are advised to get themselves tested for corona,” he tweeted.(Sant Arora/HT)
Published on Dec 06, 2020 03:38 AM IST
Copy Link
Hindustan Times, New Delhi | ByAnonna Dutt

Haryana health minister Anil Vij tests Covid-19 positive

Vij, a Bharatiya Janata Party (BJP) leader, had volunteered to be part of the third phase trial of Covaxin, which started in Haryana on November 20. He was administered a trial dose. However, it’s not immediately clear whether he was administered the vaccine candidate during the trial or a placebo.
BJP leader Anil Vij has tested positive for Covid-19.(Twitter/ANI)
BJP leader Anil Vij has tested positive for Covid-19.(Twitter/ANI)
Updated on Dec 05, 2020 02:51 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Kanishka Sarkar

Mumbai hospital continues to wait for Covaxin to begin clinical trials

The Indian Council of Medical Research (ICMR) had selected Sion hospital for the third phase, pan India trial, of Covaxin.
A medic administers Covaxin, an Indian government-backed experimental Covid-19 vaccine, to a health worker during its trials.(PTI Photo)
A medic administers Covaxin, an Indian government-backed experimental Covid-19 vaccine, to a health worker during its trials.(PTI Photo)
Updated on Dec 04, 2020 02:24 PM IST
Copy Link
Hindustan Times, Mumbai | ByRupsa Chakraborty | Edited by Abhinav Sahay

Phase 3 trial of Covaxin launched in Kolkata; state minister Firhad Hakim takes the first shot

Governor Jagdeep Dhankhar, who launched the trial, has also expressed his interest to volunteer
Phase III trial of Covaxin was launched at NICED Beleghata in Kolkata, West Bengal, on December 2.(HT photo/Samir Jana)
Phase III trial of Covaxin was launched at NICED Beleghata in Kolkata, West Bengal, on December 2.(HT photo/Samir Jana)
Updated on Dec 03, 2020 11:59 AM IST
Copy Link
Hindustan Times, Kolkata | ByHT Correspondent | Edited by Sameer

Firhad Hakim becomes second minister to administer ‘Covaxin’ trial shot

Hakim said that he will be very happy if his contribution helps in the quest for the vaccine against the coronavirus disease.
Hakim said that he will be very happy if his contribution helps in the quest for the vaccine against the coronavirus disease.(@FirhadHakim/Twitter)
Hakim said that he will be very happy if his contribution helps in the quest for the vaccine against the coronavirus disease.(@FirhadHakim/Twitter)
Updated on Dec 02, 2020 09:11 PM IST
Copy Link
Kolkata | ByPress Trust of India | Posted by Shankhyaneel Sarkar

Indigenous Covaxin phase-3 trial results in November 2021, says NICED

Covaxin, the first indigenously-developed anti-coronavirus vaccine, is being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Launch of Phase III regulatory trial of the Covaxin coronavirus vaccine, at NICED Beleghata in Kolkata.(HT Photo/Samir Jana)
Launch of Phase III regulatory trial of the Covaxin coronavirus vaccine, at NICED Beleghata in Kolkata.(HT Photo/Samir Jana)
Updated on Dec 02, 2020 07:21 PM IST
Copy Link
Hindustan Times, Kolkata | ByHT Correspondent

Bharat Biotech’s Covaxin: List of states which have started phase 3 trials of Covid-19 vaccine

On November 16, Bharat Biotech had announced the commencement of the third phase trials of Covaxin, which it has developed in collaboration with the Indian Council of Medical Research (ICMR).
FILE PHOTO: Bharat Biotech’s Covaxin is India’s first indigenous Covid-19 vaccine (REUTERS/File Photo)
FILE PHOTO: Bharat Biotech’s Covaxin is India’s first indigenous Covid-19 vaccine (REUTERS/File Photo)
Updated on Dec 02, 2020 04:04 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Phase 3 trial of Covaxin launched in Kolkata; Bengal Governor, minister offer to volunteer

Covaxin is the first Covid-19 vaccine being developed indigenously in India. Bharat Biotech is developing it in collaboration with ICMR
West Bengal Governor Jagdeep Dhankhar.(File photo)
West Bengal Governor Jagdeep Dhankhar.(File photo)
Updated on Dec 02, 2020 04:30 PM IST
Copy Link
Hindustan Times, Kolkata | ByHT Correspondent | Edited by Sameer

Covaxin phase 3 trial in Kolkata from today, TMC minister may get first shot

State Urban Development Minister Firhad Hakim, 62, is likely to take the first shot of the vaccine if he is found to be fit in the medical tests, a senior official of the institute told news agency PTI on Monday.
The phase 3 trial of coronavirus (Covid-19) vaccine candidate Covaxin will start in Kolkata on Wednesday.(PTI)
The phase 3 trial of coronavirus (Covid-19) vaccine candidate Covaxin will start in Kolkata on Wednesday.(PTI)
Published on Dec 02, 2020 07:14 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Prashasti Singh

PM congratulates scientists at Bharat Biotech for progress in Covaxin trials

The phase 3 trial is being conducted across India on 26,000 participants.
PM Modi at the Bharat Biotech facility in Hyderabad.(@narendramodi/Twitter)
PM Modi at the Bharat Biotech facility in Hyderabad.(@narendramodi/Twitter)
Updated on Nov 28, 2020 06:43 PM IST
Copy Link
Hindustan Times, Hyderabad | BySrinivasa Rao Apparasu

No complaint from volunteers given Bharat Biotech’s Covaxin: Ahmedabad doctor

Dr Parul Bhatt, the medical superintendent of the Sola Civil Hospital in Gujarat’s Ahmedabad, said the second dose of Bharat Biotech International Limited’s Covid-19 vaccine will now be given after 28 days.
People wait during the administration of Covaxin, a government-backed experimental Covid-19 vaccine, during its human trials, at the Gujarat Medical Education & Research Society in Ahmedabad, on Thursday.(PTI Photo)
People wait during the administration of Covaxin, a government-backed experimental Covid-19 vaccine, during its human trials, at the Gujarat Medical Education & Research Society in Ahmedabad, on Thursday.(PTI Photo)
Updated on Nov 27, 2020 05:41 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Meenakshi Ray

Covid-19 vaccine update: COVAXIN trials in Gujarat, AstraZeneca admits ‘error’

China National Biotec Group Company has applied to Chinese health regulators to bring its candidate to the market. In Brazil, meanwhile, America’s Pfizer Inc has started the process to get its candidate registered.
FILE PHOTO: A woman holds a small bottle labeled with a
FILE PHOTO: A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo(REUTERS)
Updated on Nov 26, 2020 05:06 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Covid-19 vaccine update: India to immunise 250 million citizens, US vaccinations might begin in December

The United Kingdom could give approval to Pfizer’s vaccine candidate this week, a report claimed. Meanwhile, the official Twitter account of Russia’s vaccine candidate Sputnik V claimed the price per dose of the vaccine would be “much lower” than that of Moderna and Pfizer’s vaccine candidates.
FILE PHOTO: Trailers are shown in a city parking lot after a Phase 3 trial location of Johnson & Johnson's Janssen (COVID-19) vaccine candidate was announced in National City during the outbreak of the coronavirus disease (COVID-19) in National City, California, U.S., October 13, 2020. REUTERS/Mike Blake(REUTERS)
FILE PHOTO: Trailers are shown in a city parking lot after a Phase 3 trial location of Johnson & Johnson's Janssen (COVID-19) vaccine candidate was announced in National City during the outbreak of the coronavirus disease (COVID-19) in National City, California, U.S., October 13, 2020. REUTERS/Mike Blake(REUTERS)
Updated on Nov 23, 2020 01:42 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Covid-19 vaccine updates: Bharat Biotech to recruit volunteers for trial, Pfizer files for emergency use authorisation

Britain’s AstraZeneca has launched phase three trials of an antibody combination drug, called AZD7442, that it hopes could be used to protect those at risk of contracting the coronavirus disease for up to 12 months.
Vials with a sticker reading,
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic
Updated on Nov 21, 2020 08:13 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Haryana health minister Anil Vij takes trial shot of Bharat Biotech’s Covid-19 vaccine

Vij, who also holds the state home portfolio, had volunteered to be the first candidate for the trial shot of Covaxin. Bharat Biotech has started conducting phase 3 trials of the vaccine candidate.
Haryana health minister Anil Vij (ANI)
Haryana health minister Anil Vij (ANI)
Updated on Nov 20, 2020 06:48 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Covid-19 vaccine update: Covaxin phase 3 trials to begin in Haryana today, minister to take shot

Adar Poonawalla, the chief executive of Serum Institute of India, said his company may sell Covishield, the Covid-19 vaccine being developed by Oxford University, for around Rs 500-600 per shot.
FILE PHOTO: Small bottles labeled with
FILE PHOTO: Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus Covid-19" words in this illustration taken April 10, 2020 (REUTERS/Dado Ruvic/Illustration/File Photo)
Updated on Nov 20, 2020 08:27 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Haryana’s Health Minister Anil Vij to be administered trial dose of Covid-19 vaccine Covaxin

Vij, who is an MLA from Ambala Cantt, had on Wednesday said the third phase of trial of Covaxin will begin in the state on November 20 and had offered to be the first volunteer to get vaccinated.
Haryana health minister Anil Vij.(Keshav Singh/Hindustan Times)
Haryana health minister Anil Vij.(Keshav Singh/Hindustan Times)
Updated on Nov 19, 2020 11:53 PM IST
Copy Link
Chandigarh | ByPress Trust of India | Posted by Shankhyaneel Sarkar

Covid-19 vaccine update: Bharat Biotech begins phase 3 trials, Moderna says its candidate nearly 95% effective

Meanwhile, Johnson and Johnson has launched a second phase 3 trial, besides its existing one. Also, India is reportedly in talks with several firms over their respective coronavirus vaccine candidates with regards to the progress of trials, vaccine efficacy, safety etc.
FILE PHOTO: A man rides his motorcycle past a parked bus of Bharat Biotech outside its office in Hyderabad (REUTERS/Stringer/File Photo)
FILE PHOTO: A man rides his motorcycle past a parked bus of Bharat Biotech outside its office in Hyderabad (REUTERS/Stringer/File Photo)
Updated on Nov 17, 2020 08:57 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Bharat Biotech starts Phase 3 trial for its anti Covid vaccine in India

The Phase III trials will involve 26,000 volunteers across India, conducted in partnership with ICMR.
Volunteers for the trial are adults above 18 years of age.(REUTERS Photo)
Volunteers for the trial are adults above 18 years of age.(REUTERS Photo)
Updated on Nov 16, 2020 08:18 PM IST
Copy Link
Hindustan Times, New Delhi | ByRhythma Kaul | Edited by Abhinav Sahay

Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ into phase-3 trials

Covaxin is being developed by BharatBiotech, in collaboration with the ICMR - National Institute of Virology (NIV).
A man rides his motorcycle past a parked bus of Indian biotechnology company Bharat Biotech outside its office in Hyderabad.(REUTERS)
A man rides his motorcycle past a parked bus of Indian biotechnology company Bharat Biotech outside its office in Hyderabad.(REUTERS)
Updated on Nov 16, 2020 07:49 PM IST
Copy Link
Hyderabad | ByPress Trust of India | Posted by Arpan Rai

Covid-19 vaccine updates: Over 250 register for Covaxin trial, Sputnik-V to reach Kanpur trial

So far, as many as 53,945,763 people have been infected by the Covid-19 across the world, numbers published by the John Hopkins University show. Most of the fresh cases were reported from the United States and Europe.
A nurse prepares Russia's ‘Sputnik-V’ vaccine against the coronavirus disease (Covid-19) for inoculation at a clinic in Tver, Russia.(Reuters)
A nurse prepares Russia's ‘Sputnik-V’ vaccine against the coronavirus disease (Covid-19) for inoculation at a clinic in Tver, Russia.(Reuters)
Updated on Nov 15, 2020 03:44 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Shivani Kumar

Doctors, MBBS students among 30 crore people to get Covid-19 vaccine first, Aadhaar not mandatory

The beneficiaries will be tracked through Aadhaar, but it won’t be mandatory. In case a person doesn’t have an Aadhaar card, any government photo identity will be used.
A volunteer getting a vaccine shot in Pune’s Bharati Hospital and Research Centre. (Photo by Ravindra Joshi/HT PHOTO)
A volunteer getting a vaccine shot in Pune’s Bharati Hospital and Research Centre. (Photo by Ravindra Joshi/HT PHOTO)
Updated on Nov 07, 2020 11:31 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Poulomi Ghosh

Covid-19 vaccine update: Bharat Biotech candidate launch and AstraZeneca’s hopes

Hungary has said it will import small doses of Russian-made Sputnik V for late stage trials, by December. Meanwhile, Australia has agreed to buy 50 million more doses of two more vaccine candidates.
A woman holds a small bottle labeled with a
A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in this illustration taken, October 30, 2020 (REUTERS/Dado Ruvic/File Photo)
Updated on Nov 06, 2020 06:43 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Bharat Biotech’s Covaxin could be launched in Feb: Govt scientist

A launch in February would make COVAXIN the first India-made vaccine to be rolled out.
Bharat Biotech’s Covaxin against coronavirus could be launched in February: Govt scientist
Bharat Biotech’s Covaxin against coronavirus could be launched in February: Govt scientist
Updated on Nov 05, 2020 04:23 PM IST
Copy Link
New Delhi | ByReuters

Bharat Biotech to launch Covaxin in Q2 2021

The company’s vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) using inactivated Sars-Cov-2, the virus that causes Covid-19. The virus was isolated in an ICMR lab.
It said its immediate focus is to conduct the Phase 3 trials successfully across sites in the country.(AP)
It said its immediate focus is to conduct the Phase 3 trials successfully across sites in the country.(AP)
Published on Nov 01, 2020 11:27 AM IST
Copy Link
Hindustan Times, New Delhi | ByPress Trust of India| Posted by Susmita Pakrasi

News updates from Hindustan Times: AIIMS to submit proposal for phase 3 trials of Covaxin next week and all the latest news

Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times
A health worker collects swab samples for Covid- 19 tests.(PTI)
A health worker collects swab samples for Covid- 19 tests.(PTI)
Updated on Oct 31, 2020 08:55 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com

News updates from Hindustan Times:Punjab farm bills offer little on ground and all the latest news

Three out of four bills passed by the Congress-led Punjab government on October 20 to negate contentious central legislations on how farmers do business are unlikely to invalidate the laws already passed by Parliament(AP)
Three out of four bills passed by the Congress-led Punjab government on October 20 to negate contentious central legislations on how farmers do business are unlikely to invalidate the laws already passed by Parliament(AP)
Updated on Oct 24, 2020 09:18 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com

Bharat Biotech to submit revised Phase 3 clinical trial protocol to DCGI by next week

Covaxin is India’s first vaccine candidate against Covid-19
Human clinical trials for Covaxin began across India in July 2020. As per the current plan, the Phase 3 trial, to determine vaccine efficacy, will begin early to mid-November this year.(Representational Photo/AP)
Human clinical trials for Covaxin began across India in July 2020. As per the current plan, the Phase 3 trial, to determine vaccine efficacy, will begin early to mid-November this year.(Representational Photo/AP)
Updated on Oct 24, 2020 08:31 AM IST
Copy Link
Hindustan Times,New Delhi | ByRhythma Kaul

Covid-19: Bharat Biotech in talks to take vaccine candidate global

The company, based in Hyderabad, this week received initial approval from Indian authorities to conduct late-stage trials for its vaccine candidate, COVAXIN.
India’s Zydus Cadila is currently conducting mid-stage trials of its own vaccine hopeful, while Serum Institute is making potential vaccines from AstraZeneca, Novavax and Codagenix Inc, as well as developing its own.(Reuters file photo. Representative image)
India’s Zydus Cadila is currently conducting mid-stage trials of its own vaccine hopeful, while Serum Institute is making potential vaccines from AstraZeneca, Novavax and Codagenix Inc, as well as developing its own.(Reuters file photo. Representative image)
Updated on Oct 23, 2020 08:41 PM IST
Copy Link
Bengaluru | ByReuters| Posted by: Harshit Sabarwal
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, December 08, 2021